Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
A universal cancer treatment for a universal cancer marker

A universal cancer treatment for a universal cancer marker

PBS-Bio announces three new contracts to develop cancer therapy

PBS-Bio announces three new contracts to develop cancer therapy

Researchers to test nanoparticle-based theranostics for pancreatic cancer treatment

Researchers to test nanoparticle-based theranostics for pancreatic cancer treatment

Neogenix to present NPC-1C antibody data at ASCO Annual Meeting

Neogenix to present NPC-1C antibody data at ASCO Annual Meeting

FibroGen announces initiation of FG-3019 phase 2 study for reversing liver fibrosis

FibroGen announces initiation of FG-3019 phase 2 study for reversing liver fibrosis

Humanitas Clinic treats first cancer patient using TrueBeam technology

Humanitas Clinic treats first cancer patient using TrueBeam technology

Threshold announces TH-302 Phase 1/2 clinical trial interim results

Threshold announces TH-302 Phase 1/2 clinical trial interim results

Scientists design synthetic molecule to protect liver cancer cells from toxic effects of chemotherapy

Scientists design synthetic molecule to protect liver cancer cells from toxic effects of chemotherapy

Cancer patients getting unnecessary tests: Study

Cancer patients getting unnecessary tests: Study

Infinity announces preliminary results of IPI-926 Phase 1 study in patients with solid tumors

Infinity announces preliminary results of IPI-926 Phase 1 study in patients with solid tumors

Researchers develop new technique to detect lung cancer

Researchers develop new technique to detect lung cancer

Role of TGF-ß in cancer diseases

Role of TGF-ß in cancer diseases

American Cancer Society awards 94 national research, training grants to 70 institutions nationwide

American Cancer Society awards 94 national research, training grants to 70 institutions nationwide

Decision Resources: NSCLC drug market to grow from $4 billion in 2009 to over $6.5 billion in 2019

Decision Resources: NSCLC drug market to grow from $4 billion in 2009 to over $6.5 billion in 2019

UAB Comprehensive Cancer Center wins $11.5M grant for pancreatic cancer research

UAB Comprehensive Cancer Center wins $11.5M grant for pancreatic cancer research

Duke receives approval to initiate NPC-1C Phase I trial for advanced pancreatic and colorectal cancer

Duke receives approval to initiate NPC-1C Phase I trial for advanced pancreatic and colorectal cancer

UNC scientists receive grant to develop targeted delivery system for pancreatic cancer

UNC scientists receive grant to develop targeted delivery system for pancreatic cancer

Researchers identify biomarkers for mesothelioma and pancreatic cancer

Researchers identify biomarkers for mesothelioma and pancreatic cancer

Biothera receives SBIR award to evaluate therapeutic potential of Imprime PGG drug in pancreatic cancer

Biothera receives SBIR award to evaluate therapeutic potential of Imprime PGG drug in pancreatic cancer

Asuragen announces results of study evaluating RNA-based assay for detection of common NPM1 mutations

Asuragen announces results of study evaluating RNA-based assay for detection of common NPM1 mutations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.